TETRALYSAL 300 mg, hard capsule 28 capsules
Active ingredients: Lymecycline, Tetracycline
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule28 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TETRALYSAL 300 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- film(s) thermosoudé(s) aluminium polyéthylène de 28 gélule(s)
- Marketing authorisation holder
- GALDERMA INTERNATIONAL
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Apr 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60891060CIP73675980CIP133400936759800Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TÉTRACYCLINEgélule | 300 mg · une gélule | FT |
| LYMÉCYCLINEgélule | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.